Bank of America’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Bank of America’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$800	–	7398
2025 Q3	$800	Hold	100	–	–	﹤0.01%	7522
2025 Q2	$800	Hold	100	–	–	﹤0.01%	7576
2025 Q1	$315	Buy	+100	New	+$6.05K	﹤0.01%	7601
2024 Q3	–	Sell	-7	Closed	-$78	–	8168
2024 Q2	$78	Sell	7 -93	-93%	-$2.39K	﹤0.01%	7753
2024 Q1	$414	Buy	+100	New	+$1.1K	﹤0.01%	7293

Other funds holding BBLGW

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America's BBLGW Position: Q4 2025 in Review

Bank of America sold out of Bone Biologics Corp Warrants (BBLGW) in Q4 2025, closing a stake of 100 shares — an estimated $800 sold.

Bank of America first reported a position in BBLGW in Q1 2024 and held it in 5 quarters. The position peaked at $800 in Q3 2025. 2 funds tracked by Wall St. Rank hold BBLGW as of Q4 2025.

Bank of America reported no remaining Bone Biologics Corp Warrants position as of Q4 2025 after selling out during the quarter.
Bank of America sold 100 Bone Biologics Corp Warrants shares in Q4 2025, an estimated $800.
Bank of America first reported a position in Bone Biologics Corp Warrants in Q1 2024 and held it in 5 quarters.
Bank of America's Bone Biologics Corp Warrants position peaked at $800 in Q3 2025.
2 funds tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.